The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 546.00
Bid: 542.00
Ask: 550.00
Change: 28.00 (5.41%)
Spread: 8.00 (1.476%)
Open: 518.00
High: 550.00
Low: 518.00
Prev. Close: 546.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MuCell Extrusion LLC Obtains an Exclusive License

14 Aug 2012 07:00

RNS Number : 9308J
Zotefoams PLC
14 August 2012
 



14 August 2012

 

Zotefoams plc

("Zotefoams" or "the Company")

 

 

MuCell Extrusion LLC Obtains an Exclusive License for Styron's

Extruded Styrenic Foam Sheet Patent Portfolio, including Polystyrene, ABS and SAN

 

MuCell Extrusion LLC and Styron (Berwyn, Pennsylvania) have concluded an agreement for MuCell Extrusion LLC to acquire access to Styron's patent portfolio for extrusion of Styrenic resins. This agreement gives MuCell Extrusion and its customers exclusive rights to the Styron patents related to Sheet technology for a wide variety of applications.

 

This agreement creates a significant strategic alliance between two companies with leading experience in the successful development and application of physical blowing agents to produce superior foamed products.

 

The combination of Styron's CO2RE™ technology and MuCell's expertise around technology and hardware is expected to help customers improve their competitive advantage in a shorter timeframe. Sheet for thermoforming, FFS, roll stock, paneling and high volume packaging will all see significant cost reductions by applying this technology.

 

 "CO2RE™ is a patented plastic foaming technology that produces polystyrene sheets with a foamed core layer using physical blowing agents," said John Case, Styrenics Global Marketing Manager, Styron. "The technology provides a good opportunity for the packaging market, where for example dairy and food service industries can improve their sustainability by reducing the density and weight of their product packaging. It also provides benefits in reduced energy and reduced raw material usage, as well as lower packaging waste disposable tax in the EU."

 

"MuCell provides expertise in Process and Equipment development, and Styron offers formulation expertise in resins. We believe this combination will bring significant benefits to our customers," said Mark Lindenfelzer, President of MuCell. "The combination of our own patents and intellectual property, and Styron's patents now gives our customers the opportunity to apply the most advanced foaming technology in their products," he said.

 

About MuCell Technology

MuCell technology is based on the direct injection of atmospheric gas (N2 or CO2) in its supercritical state. MuCell has applied this technology to most plastic materials and processes. Rigid sheet, low-density flexible sheet, Blown film, Cast film, pipe/tubing/profile, and blow molding manufacturing processes are all current applications using MuCell technology. MuCell's innovative and accessible technology brings significant material weight-savings and cost reduction opportunities, without compromising physical product performance.

 

Earlier this year, Dow Chemical and MuCell reached an agreement for MuCell to acquire exclusive rights to Dow's patent portfolio for flat sheet resin technology, and more recently Dow's patents for Foam Film technology.

 

The corporate headquarters of MuCell Extrusion LLC are located at 212 West Cummings Park, Woburn, MA 01810. MuCell Extrusion is a wholly owned subsidiary of Zotefoams plc, UK (ZTF on LSE). For more information, please visit www.mucellextrusion.com.

 

About Styron

Styron is a leading global materials company and manufacturer of plastics, latex and rubber, dedicated to collaborating with customers to deliver innovative and sustainable solutions. Styron's technology is used by customers in industries such as home appliances, automotive, building & construction, carpet, consumer electronics, consumer goods, electrical & lighting, medical, packaging, paper & paperboard, rubber goods and tires. Styron had approximately $6 billion in revenue in 2011, with 20 manufacturing sites around the world, and 2100 employees. More information can be found at www.styron.com.

 

###

 

For Styron editorial information please contact:

Donna St. Germain, Styron

Tel. +1 610 240 3307

stgermain@styron.com

 

 

For information on MuCell Extrusion LLC and Zotefoams plc contact:

 

Zotefoams plc

Clifford Hurst or David Stirling

+44 20 8664 1600

 

FTI Consulting

John Dineen / Victoria Foster Mitchell

+44 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKNDDFBKDPFD
Date   Source Headline
27th Sep 20227:00 amRNSIndependent Life Cycle Assessment of ReZorce
13th Sep 20223:43 pmRNSDirector/PDMR Shareholding
23rd Aug 20224:35 pmRNSPrice Monitoring Extension
22nd Aug 20224:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:36 pmRNSPrice Monitoring Extension
12th Aug 20221:43 pmRNSDirector/PDMR Shareholding
11th Aug 20223:50 pmRNSHolding(s) in Company
9th Aug 20227:00 amRNSInterim Results
2nd Aug 20224:35 pmRNSPrice Monitoring Extension
20th Jul 20224:42 pmRNSSecond Price Monitoring Extn
20th Jul 20224:36 pmRNSPrice Monitoring Extension
12th Jul 202212:39 pmRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSNotice of Results
30th Jun 20224:52 pmRNSDirector/PDMR Shareholding
8th Jun 20224:40 pmRNSSecond Price Monitoring Extn
8th Jun 20224:35 pmRNSPrice Monitoring Extension
8th Jun 20228:49 amRNSDirector/PDMR Shareholding
26th May 20224:41 pmRNSSecond Price Monitoring Extn
26th May 20224:36 pmRNSPrice Monitoring Extension
25th May 20221:04 pmRNSResult of the 2022 Annual General Meeting
25th May 20227:00 amRNSTrading Update
18th May 20224:41 pmRNSSecond Price Monitoring Extn
18th May 20224:36 pmRNSPrice Monitoring Extension
12th May 20223:58 pmRNSDirector/PDMR Shareholding
11th May 20222:13 pmRNSDirector/PDMR Shareholding
25th Apr 20225:16 pmRNSDirector/PDMR Shareholding
25th Apr 20227:00 amRNS2021 Annual Report and Notice of the 2022 AGM
11th Apr 20223:49 pmRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSPreliminary Results
14th Mar 202212:30 pmRNSDirector/PDMR Shareholding
25th Feb 20227:00 amRNSNotice of results and investor presentation
15th Feb 20224:26 pmRNSDirector/PDMR Shareholding
27th Jan 20227:00 amRNSFull Year Trading Update
12th Jan 202211:12 amRNSDirector/PDMR Shareholding
23rd Dec 20211:56 pmRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSTrading Update
14th Dec 202111:55 amRNSDirector/PDMR Shareholding
12th Nov 202112:41 pmRNSDirector/PDMR Shareholding
10th Nov 20215:48 pmRNSHolding(s) in Company
4th Nov 20215:59 pmRNSHolding(s) in Company
4th Nov 20213:31 pmRNSDirector/PDMR Shareholding
3rd Nov 20217:00 amRNSQ3 Trading Update
15th Oct 202112:10 pmRNSDirector/PDMR Shareholding
12th Oct 202111:05 amRNSDirector/PDMR Shareholding
1st Oct 20213:31 pmRNSHolding(s) in Company
14th Sep 202110:05 amRNSDirector/PDMR Shareholding
12th Aug 20212:28 pmRNSDirector/PDMR Shareholding
10th Aug 20217:00 amRNSInterim Results
19th Jul 20219:26 amRNSNotice of Results
13th Jul 20211:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.